Case series of 226 γ-hydroxybutyrate-associated deaths: Lethal toxicity and trauma

American Journal of Emergency Medicine

Volumn 29, Issue 3, 2011, Pages 319-332

  Zvosec, Deborah L ^a,b   Smith, Stephen W ^a,c   Porrata, Trinka ^d   Strobl, A Quinn ^e   Dyer, Jo Ellen ^f,g  

^a HENNEPIN COUNTY MEDICAL CENTER   (United States)

^b MINNEAPOLIS MEDICAL RESEARCH FOUNDATION   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d Project GHB   (United States)

^e Anoka County Medical Examiner   (United States)

^f California Poison Control System   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYBUTYRIC ACID;

ACCIDENT; ADOLESCENT; ADULT; AUTOPSY; BLOOD ANALYSIS; CARDIOPULMONARY INSUFFICIENCY; CASE STUDY; FEMALE; HUMAN; INJURY; INTOXICATION; LETHALITY; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; TOXICOLOGY; URINALYSIS;

ADOLESCENT; ADULT; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SODIUM OXYBATE; STREET DRUGS; SUBSTANCE-RELATED DISORDERS; UNITED STATES; YOUNG ADULT;

EID: 79951909577     PISSN: 07356757     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajem.2009.11.008     Document Type: Review

References (97)

1. Dyer J.E. Gamma-hydroxybutyrate: a health-food product producing coma and seizurelike activity Am J Emerg Med 9 1991 321 324
2. Zvosec D.L., Smith S.W., McCutcheon J.R., Spillane J., Hall B.J., and Peacock E.A. Adverse events, including death, associated with the use of 1,4-butanediol N Engl J Med 344 2001 87 94 (Pubitemid 32052497)
3. Dargan P.I., Jayachandran A., and Button J. A significant Xyrem overdose managed conservatively despite high GHB concentrations (Abstract 251) Clin Tox 46 2008 636
4. Suner S., Szlatenyi C.S., and Wang R.Y. Pediatric gamma hydroxybutyrate intoxication Acad Emerg Med 4 1997 1041 1045 (Pubitemid 27485996)
5. Higgins T.F. Jr., and Borron S.W. Coma and respiratory arrest after exposure to butyrolactone J Emerg Med 14 1996 435 437 (Pubitemid 26362408)
6. Brown J.J., and Nanayakkara C.S. Acetone-free nail polish removers: are they safe? Clin Toxicol (Phila) 43 2005 297 299 (Pubitemid 41073030)
7. Gunja N., Doyle E., and Carpenter K. Gamma-hydroxybutyrate poisoning from toy beads Med J Aust 188 2008 54 55
8. Xyrem (sodium oxybate) oral solution. http://jazzph.isat-tech.com/media/ PI.pdf. Accessed 2/5/2009.
9. Couper F.J., and Logan B.K. GHB and driving impairment J Forensic Sci 46 2001 919 923 (Pubitemid 32601273)
10. Zvosec D.L., and Smith S.W. Acute complications of gamma hydroxybutyrate addiction (Abstract) Acad Emerg Med 12 2005 S13
11. Couper F.J., and Logan B.K. Addicted to driving under the influence-a GHB/GBL case report J Anal Toxicol 28 2004 512 515 (Pubitemid 39150376)
12. Liechti M.E., Kunz I., Greminger P., Speich R., and Kupferschmidt H. Clinical features of gamma-hydroxybutyrate and gamma-butyrolactone toxicity and concomitant drug and alcohol use Drug Alcohol Depend 81 2006 323 326 (Pubitemid 43152459)
13. Zvosec D.L., and Smith S.W. Agitation is common in gamma-hydroxybutyrate toxicity Am J Emerg Med 23 2005 316 320
14. Dyer J.E., Roth B., and Hyma B.A. Gamma-hydroxybutyrate withdrawal syndrome Ann Emerg Med 37 2001 147 153 (Pubitemid 32142960)
15. Benjamin D.M. Gamma-hydroxybutyrate (GHB)-withdrawal with severe rhabdomyolysis, hyperkalemia, and cardiac arrest (Abstract K4) Proceedings of the American Academy of Forensic Sciences, San Antonio, TX vol. XIII 2007
16. Theron L., Jansen K., and Skinner A. New Zealand's first fatality linked to use of 1,4-butanediol (1,4-B, Fantasy): no evidence of coingestion or comorbidity N Z Med J 116 2003 U650
17. Viswanathan S., Chen C., and Kolecki P. Revivarant (gamma-butyrolactone) poisoning Am J Emerg Med 18 2000 358 359
18. Gagajewski A., and Apple F.S. Methadone-related deaths in Hennepin County, Minnesota: 1992-2002 J Forensic Sci 48 2003 668 671 (Pubitemid 36538842)
19. Logan B.K., Fligner C.L., and Haddix T. Cause and manner of death in fatalities involving methamphetamine J Forensic Sci 43 1998 28 34 (Pubitemid 28063701)
20. Patel M.M., Wright D.W., Ratcliff J.J., and Miller M.A. Shedding new light on the "safe" club drug: methylenedioxymethamphetamine (ecstasy)-related fatalities Acad Emerg Med 11 2004 208 210 (Pubitemid 38166978)
21. Graham J.K., and Hanzlick R. Accidental drug deaths in Fulton County, Georgia, 2002: characteristics, case management and certification issues Am J Forensic Med Pathol 29 2008 224 230
22. Kintz P., Villain M., Cirimele V., and Ludes B.G.H.B. in postmortem toxicology. Discrimination between endogenous production from exposure using multiple specimens Forensic Sci Int 143 2004 177 181 (Pubitemid 38881446)
23. Elliott S. The presence of gamma-hydroxybutyric acid (GHB) in postmortem biological fluids. Letter to the Editor J Anal Toxicol 25 2001 152 (Pubitemid 32205333)
24. Elliott S.P. Further evidence for the presence of GHB in postmortem biological fluid: implications for the interpretation of findings J Anal Toxicol 28 2004 20 26 (Pubitemid 38112313)
25. Marinetti L.J., Isenschmid D.S., Hepler B.R., and Kanluen S. Analysis of GHB and 4-methyl-GHB in postmortem matrices after long-term storage J Anal Toxicol 29 2005 41 47 (Pubitemid 40128944)
26. Moriya F., and Hashimoto Y. Endogenous gamma-hydroxybutyric acid levels in postmortem blood Bull Int Assoc Forensic Toxicol 35 2005 51
27. Anderson D.T., and Kuwahara T. Endogenous gamma hydroxybutyrate (GHB) levels in postmortem specimens Abstract presented at the CAT/NWAFS/SWAFS/SAT Joint Meeting, Las Vegas, NV. November 3-7 1997
28. Elliott S.P. Gamma hydroxybutyric acid (GHB) concentrations in humans and factors affecting endogenous production Forensic Sci Int 133 2003 9 16 (Pubitemid 36555414)
29. LeBeau M.A., Montgomery M.A., Morris-Kukoski C., Schaff J.E., Deakin A., and Levine B. A comprehensive study on the variations in urinary concentrations of endogenous gamma-hydroxybutyrate (GHB) J Anal Toxicol 30 2006 98 105
30. Barker S.A., Snead O.C., Poldrugo F., Liu C.C., Fish F.P., and Settine R.L. Identification and quantitation of 1,4-butanediol in mammalian tissues: an alternative biosynthetic pathway for gamma-hydroxybutyric acid Biochem Pharmacol 34 1985 1849 1852 (Pubitemid 15096601)
31. Anderson D.T., Muto J.J., and Andrews J.M. Case report: post mortem tissue distribution of gamma hydroxybutyrate (GHB) and gamma butyrolactone (GBL) in a single fatality (Abstract) Annual Meeting of the Society of Forensic Toxicologists, Milwaukee, Wisconsin 2000
32. Chavez-Arias C.F. Three gamma-hydroxybutyrate-related deaths (Abstract) Annual Meeting of the American Academy of Forensic Sciences, Seattle, Washington 2006
33. Duer W.C., Byers K.L., and Martin J.V. Application of a convenient extraction procedure to analyze gamma-hydroxybutyric acid in fatalities involving gamma-hydroxybutyric acid, gamma-butyrolactone, and 1,4-butanediol J Anal Toxicol 25 2001 576 582 (Pubitemid 32939061)
34. Harty L., and Kemp P. Postmortem distribution of gamma-hydroxybutyrate: 2 cases from Oklahoma (Abstract) Spring Meeting of the Southwestern Association of Toxicologists, Wichita, Kansas 2002
35. Marinetti L.J., Isenschmid D.S., Hepler B.R., Somerset J.S., and Kanluen S. Two gamma-hydroxybutyric acid (GHB) fatalities Presented at the American Academy of Forensic Sciences Annual Meeting, Reno, NV 2000
36. Mazarr-Proo S., and Kerrigan S. Fatal GHB intoxication following recreational use Abstract Annual Meeting of the Society of Forensic Toxicologists., Washington D.C., August-September 2004
37. Pan M., Wall W.H., and Solomons E.T. GHB in Georgia, 1996-1998 (Abstract) Annual Meeting of the American Academy of Forensic Sciences, Orlando, Florida 1999
38. Snead O.C. III, and Gibson K.M. Gamma-hydroxybutyric acid N Engl J Med 352 2005 2721 2732
39. Borgen L.A., Okerholm R.A., Lai A., and Scharf M.B. The pharmacokinetics of sodium oxybate oral solution following acute and chronic administration to narcoleptic patients J Clin Pharmacol 44 2004 253 257 (Pubitemid 38233822)
40. Abanades S., Farre M., and Segura M. Disposition of gamma-hydroxybutyric acid in conventional and nonconventional biologic fluids after single drug administration: issues in methodology and drug monitoring Ther Drug Monit 29 2007 64 70 (Pubitemid 46279878)
41. Thai D., Dyer J.E., Benowitz N.L., and Haller C.A. Gamma-hydroxybutyrate and ethanol effects and interactions in humans J Clin Psychopharmacol 26 2006 524 529 (Pubitemid 44401479)
42. Borgen L.A., Okerholm R., Morrison D., and Lai A. The influence of gender and food on the pharmacokinetics of sodium oxybate oral solution in healthy subjects J Clin Pharmacol 43 2003 59 65 (Pubitemid 36015444)
43. Abanades S., Farre M., and Barral D. Relative abuse liability of gamma-hydroxybutyric acid, flunitrazepam, and ethanol in club drug users J Clin Psychopharmacol 27 2007 625 638 (Pubitemid 351339451)
44. Carter L.P., Griffiths R.R., and Mintzer M.Z. Cognitive, psychomotor, and subjective effects of sodium oxybate and triazolam in healthy volunteers Psychopharmacology (Berl) 206 2009 141 154
45. Brenneisen R., Elsohly M.A., and Murphy T.P. Pharmacokinetics and excretion of gamma-hydroxybutyrate (GHB) in healthy subjects J Anal Toxicol 28 2004 625 630 (Pubitemid 39489034)
46. Carter L.P., Richards B.D., Mintzer M.Z., and Griffiths R.R. Relative abuse liability of GHB in humans: a comparison of psychomotor, subjective, and cognitive effects of supratherapeutic doses of triazolam, pentobarbital, and GHB Neuropsychopharmacology 31 2006 2537 2551 (Pubitemid 44607073)
47. Metcalf D.R., Emde R.N., and Stripe J.T. An EEG-behavioral study of sodium hydroxybutyrate in humans Electroenceph Clin Neurophysiol 20 1966 506 512
48. Miotto K., Darakjian J., Basch J., Murray S., Zogg J., and Rawson R. Gamma-hydroxybutyric acid: patterns of use, effects and withdrawal Am J Addict 10 2001 232 241 (Pubitemid 32879089)
49. Thai D., Dyer J.E., Jacob P., and Haller C.A. Clinical pharmacology of 1,4-butanediol and gamma-hydroxybutyrate after oral 1,4-butanediol administration to healthy volunteers Clin Pharmacol Ther 81 2007 178 184 (Pubitemid 46174814)
50. Degenhardt L., Darke S., and Dillon P. GHB use among Australians: characteristics, use patterns and associated harm Drug Alcohol Depend 67 2002 89 94 (Pubitemid 34615930)
51. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) GHB and its precursor GBL: an emerging trend case study 2008 European Monitoring Centre for Drugs and Drug Addiction Lisbon (Portugal)
52. Knudsen K., Greter J., and Verdicchio M. High mortality rates among GHB abusers in Western Sweden Clin Toxicol (Phila) 46 2008 187 192 (Pubitemid 351398402)
53. Gable R.S. Acute toxic effects of club drugs J Psychoactive Drugs 36 2004 303 313 (Pubitemid 39383167)
54. Anderson I.B., Kim S.Y., and Dyer J.E. Trends in gamma-hydroxybutyrate (GHB) and related drug intoxication: 1999 to 2003 Ann Emerg Med 47 2006 177 183 (Pubitemid 43121089)
55. Bronstein A.C., Spyker D.A., Cantilena L.R. Jr., Green J., Rumack B.H., and Heard S.E. 2006 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS) Clin Toxicol (Phila) 45 2007 815 917
56. Bronstein A.C., Spyker D.A., Cantilena L.R. Jr., Green J.L., Rumack B.H., and Heard S.E. 2007 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 25th Annual Report Clin Toxicol (Phila) 46 2008 927 1057
57. Johnston L.D., O'Malley P.M., Bachman J.G., and Schulenberg J.E. Monitoring the future: national results on adolescent drug use, overview of key findings: 2008 2009 National Institute on Drug Abuse, National Institutes of Health, U.S. Department of Health and Human Services Bethesda (Md)
58. Galicia M., Nogue S., To-Figueras J., Echarte J.L., Iglesias M.L., and Miro O. Poisoning by liquid ecstasy (GHB) in hospital emergency departments of Barcelona: a 2-years study Med Clin (Barc) 130 2008 254 258 (Pubitemid 351520648)
59. Jones A.W., Holmgren A., and Kugelberg F.C. Gamma-hydroxybutyrate concentrations in the blood of impaired drivers, users of illicit drugs, and medical examiner cases J Anal Toxicol 31 2007 566 572 (Pubitemid 350291668)
60. Dietze P.M., Cvetkovski S., Barratt M.J., and Clemens S. Patterns and incidence of gamma-hydroxybutyrate (GHB)-related ambulance attendances in Melbourne, Victoria Med J Aust 188 2008 709 711
61. Wojtowicz J.M., Yarema M.C., and Wax P.M. Withdrawal from gamma-hydroxybutyrate, 1,4-butanediol, and gamma-butyrolactone: a case report and systematic review CJEM 10 2008 69 74
62. Glasper A., McDonough M., and Bearn J. Within-patient variability in clinical presentation of gamma-hydroxybutyrate withdrawal: a case report Eur Addict Res 11 2005 152 154 (Pubitemid 40910984)
63. Garvey R., and Fitzmaurice B. Withdrawal delirium with dance drug "liquid ecstasy" (GHB) Irish J Psych Med 21 2004 73 75 (Pubitemid 39214590)
64. Personal communication from Trinka Porrata. President, ProjectGHB, www.projectGHB.org.
65. Australian Crime Commission Illicit Drug Data Report: 2005-2006 2007 Australian Crime Commission Canberra City
66. Caldicott D.G., Chow F.Y., Burns B.J., Felgate P.D., and Byard R.W. Fatalities associated with the use of gamma-hydroxybutyrate and its analogues in Australasia Med J Aus 181 2004 310 313 (Pubitemid 39302713)
67. Advisory Council on the Misuse of Drugs (ACMD) GBL & 1,4-BD: assessment of risk to the individual and communities in the UK 2007 National Programme on Substance Abuse Deaths (np-SAD), International Centre for Drug Policy London
68. Knudsen K. Intoxication with gamma-hydroxybutyric acid (GHB) is an increasing social and medical emergency in Sweden (Abstract) J Tox Clin Toxicol 38 2000 226
69. Hearn W.L., and Walls H.C. Introduction to post-mortem toxicology S.B. Karch, Drug abuse handbook 2007 CRC Press New York 965 975
70. Li J., Stokes S.A., and Woeckener A. A tale of novel intoxication: seven cases of gamma-hydroxybutyric acid overdose Ann Emerg Med 31 1998 723 728 (Pubitemid 28252628)
71. Kim S.Y., Anderson I.B., Dyer J.E., Barker J.C., and Blanc P.D. High-risk behaviors and hospitalizations among gamma hydroxybutyrate (GHB) users Am J Drug Alcohol Abuse 33 2007 429 438 (Pubitemid 47037168)
72. Moriya F., and Hashimoto Y. Site-dependent production of gamma-hydroxybutyric acid in the early postmortem period Forensic Sci Int 148 2005 139 142 (Pubitemid 40082403)
73. Abanades S., Farre M., and Segura M. Gamma-hydroxybutyrate (GHB) in humans: pharmacodynamics and pharmacokinetics Ann N Y Acad Sci 1074 2006 559 576 (Pubitemid 44532860)
74. Borgen L., Lane E., and Lai A. Xyrem (sodium oxybate): a study of dose proportionality in healthy human subjects J Clin Pharmacol 40 2000 1053
75. Helrich M., McAsian T., and Skolnick S. Correlation of blood levels of 4-hydroxybutyrate with state of consciousness Anesthesiology 25 1964 771 775
76. Couper F.J., Thatcher J.E., and Logan B.K. Suspected GHB overdoses in the emergency department J Anal Toxicol 28 2004 481 484 (Pubitemid 39150369)
77. Couper F.J., and Logan B.K. Determination of gamma-hydroxybutyrate (GHB) in biological specimens by gas chromatography-mass spectrometry J Anal Toxicol 24 2000 1 7 (Pubitemid 30053891)
78. Dyer J.E., Isaacs S.M., and Keller K.H. Gamma hydroxybutyrate (GHB)-induced coma with serum and urine drug levels Vet Human Toxicol 36 1994 348
79. Lenz D., Rothschild M.A., and Kroner L. Intoxications due to ingestion of gamma-butyrolactone: organ distribution of gamma-hydroxybutyric acid and gamma-butyrolactone Ther Drug Monit 30 2008 755 761
80. Megarbane B., Fompeydie D., Garnier R., and Baud F.J. Treatment of a 1,4-butanediol poisoning with fomepizole J Toxicol Clin Toxicol 40 2002 77 80 (Pubitemid 34438294)
81. Strickland R.M., Felgate P., and Caldicott D.G. Survival of massive gamma-hydroxybutyrate/ 1,4-butanediol overdose Emerg Med Australas 17 2005 281 283 (Pubitemid 41025679)
82. Zvosec D.L., Smith S.W., and Hall B.J. Three deaths associated with use of Xyrem (R) Sleep Med 10 2009 490 493
83. Akins B.E., Miranda E., Matthew Lacy J., and Logan B.K. A Multi-Drug Intoxication Fatality Involving Xyrem (GHB) J Forensic Sci 54 2009 495 496
84. Garriott J.C. Analysis for alcohol in postmortem specimens J.C. Garriott, Medical-legal aspects of alcohol 2003 Lawers and Judges Publishing Company, Inc Tucson (Ariz) 163 176
85. Zvosec D., Smith S.W., Porrata T., Strobl A.Q., and Dyer J.E. 226 gamma hydroxybutyrate (GHB)-associated fatalities: overlap of postmortem GHB levels with endogenous, therapeutic, and non-fatal GHB toxicity cases and factors supporting exogenous origin Presentation at the Annual Meeting of the National Association of Medical Examiners, Savannah, Ga, October 13 2007
86. Fieguth A., Albrecht K., Weller J.P., Kuhnle R., and Teske J. First report of lethal gamma-hydroxybutyrate (GHB) intoxication after consumption of gamma-butyrolactone (GBL) in Lower Saxony Arch Kriminol 223 2009 45 51
87. Tracy M., Piper T.M., and Ompad D. Circumstances of witnessed drug overdose in New York City: implications for intervention Drug Alcohol Depend 79 2005 181 190 (Pubitemid 40942108)
88. Prescription GHB. http://www.drugs-forum.com/forum/archive/index.php/t- 1723.html. Accessed 9/23/2009.
89. Zvosec D.L., Smith S.W., Litonjua R., and Westfal R.E. Physostigmine for gamma-hydroxybutyrate coma: inefficacy, adverse events, and review Clin Toxicol (Phila) 45 2007 261 265 (Pubitemid 46525186)
90. Lowenfels A.B., and Miller T.T. Alcohol and trauma Ann Emerg Med 13 1984 1056 1060
91. Xyrem (sodium oxybate) oral solution 2002 Orphan Medical, Inc Minnetonka (Minn) Package insert Part No. 542599 Rev 0702
92. Dempsey D.A., Meyers M., Fiorentino D., Haller C.A., Benowitz N.L., and Murphy N. Gamma-hydroxybutyrate (GHB) effects upon driving a car (Abstract) Clin Pharmacol Ther 83 2008 S75
93. Barker J.C., and Karsoho H. Hazardous use of gamma hydroxybutyrate: driving under the influence Subst Use Misuse 43 2008 1507 1520
94. McKay M.P., and Garrison H.G. Commentary: reducing drunk driving: what is the role of emergency physicians Ann Emerg Med 46 2005 553 555 (Pubitemid 41676756)
95. Hungerford D.W., Williams J.M., and Furbee P.M. Feasibility of screening and intervention for alcohol problems among young adults in the ED Am J Emerg Med 21 2003 14 22 (Pubitemid 36176124)
96. ACEP Policy statements: alcohol screening in the emergency department Ann Emerg Med 46 2005 215
97. D'Onofrio G., Pantalon M.V., and Degutis L.C. Brief intervention for hazardous and harmful drinkers in the emergency department Ann Emerg Med 51 2008 742 750